Filter posts

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading …

NIH & NSF SBIR/STTR Programs

Leveraging Small Business to Bring Life-Saving Innovations to the Market. A key part of the …

BIO to Labor/HHS: Increase Funding for Critical Public Health Programs

BIO sent a letter to appropriators to encourage support for programs and initiatives that are …

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, …

Legislative Hopes, Fears

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …

Public Health at Risk: Don’t Cut Programs that Work

In order to avoid the “fiscal cliff,” the Congress must compromise and protect our economic …

Research: Working Together Toward Cures

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require …

Sequestration Will Be Devastating to the Cure Enterprise

For months, the defense industry has taken the Hill and media outlets by storm detailing …

Let's Get PDUFA V Approved, Fast

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At …